1-3 of 3
Wei Zhong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628

Darwin A. Garcia, Sneha Rathi, Margaret A. Connors, Michael Grams, Rachael A. Vaubel, Katrina K. Bakken, Lauren L. Ott, Brett L. Carlson, Zeng Hu, Paul A. Decker, Jeanette E. Eckel-Passow, Danielle M. Burgenske, Wei Zhong, Joshua D. Trzasko, Michael G. Herman, William F. Elmquist, Nicholas B. Remmes, Jann N. Sarkaria
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF11.
https://doi.org/10.1158/1535-7163.MCT-24-0664
Published: 09 December 2024
View article titled, Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628
Open the PDF for Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628 in another window
Includes: Supplementary data
Journal Articles

Abstract A148: The radiosensitizing effects of the novel brain penetrant and potent ATM inhibitor WSD0628 in glioblastoma and melanoma patient derived xenografts

Zhiyi Xue, Ann C. Mladek, Sneha Rathi, Danielle M. Burgenske, Shiv K. Gupta, Brett L. Carlson, Zeng Hu, Lauren L Ott, Katrina K. Bakken, Rachael A. Vaubel, William F Elmquist, Wei Zhong, Jann N Sarkaria
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): A148.
https://doi.org/10.1158/1535-7163.TARG-23-A148
Published: 01 December 2023
View article titled, Abstract A148: The radiosensitizing effects of the novel brain penetrant and potent ATM inhibitor WSD0628 in glioblastoma and melanoma patient derived xenografts
Journal Articles

Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Sun Young Rha, Pavani Chalasani, Wei Zhong, Li Zhou, Steven Pirie-Shepherd, Abraham C.F. Leung, Giuseppe Curigliano
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (10): 1191–1203.
https://doi.org/10.1158/1535-7163.MCT-23-0101
Published: 02 October 2023
View article titled, Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study
Open the PDF for Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study in another window
Includes: Supplementary data